RCUS
Price
$9.15
Change
-$0.27 (-2.87%)
Updated
Jul 18 closing price
Capitalization
968.85M
10 days until earnings call
TLPPF
Price
$15.90
Change
+$0.13 (+0.82%)
Updated
Jul 18 closing price
Capitalization
5.52B
Interact to see
Advertisement

RCUS vs TLPPF

Header iconRCUS vs TLPPF Comparison
Open Charts RCUS vs TLPPFBanner chart's image
Arcus Biosciences
Price$9.15
Change-$0.27 (-2.87%)
Volume$437.3K
Capitalization968.85M
Telix Pharmaceutical
Price$15.90
Change+$0.13 (+0.82%)
Volume$2.16K
Capitalization5.52B
RCUS vs TLPPF Comparison Chart in %
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. TLPPF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and TLPPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (RCUS: $9.15 vs. TLPPF: $15.90)
Brand notoriety: RCUS and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 43% vs. TLPPF: 49%
Market capitalization -- RCUS: $968.85M vs. TLPPF: $5.52B
RCUS [@Biotechnology] is valued at $968.85M. TLPPF’s [@Biotechnology] market capitalization is $5.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 4 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than TLPPF.

Price Growth

RCUS (@Biotechnology) experienced а -1.93% price change this week, while TLPPF (@Biotechnology) price change was +4.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($5.52B) has a higher market cap than RCUS($969M). TLPPF YTD gains are higher at: 6.177 vs. RCUS (-38.549). TLPPF has higher annual earnings (EBITDA): 92.5M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. TLPPF (710M). RCUS has less debt than TLPPF: RCUS (60M) vs TLPPF (581M). TLPPF has higher revenues than RCUS: TLPPF (783M) vs RCUS (141M).
RCUSTLPPFRCUS / TLPPF
Capitalization969M5.52B18%
EBITDA-377M92.5M-408%
Gain YTD-38.5496.177-624%
P/E RatioN/A168.57-
Revenue141M783M18%
Total Cash997M710M140%
Total Debt60M581M10%
FUNDAMENTALS RATINGS
RCUS vs TLPPF: Fundamental Ratings
RCUS
TLPPF
OUTLOOK RATING
1..100
1485
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
10018
SMR RATING
1..100
9774
PRICE GROWTH RATING
1..100
6158
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCUS's Valuation (53) in the Pharmaceuticals Major industry is somewhat better than the same rating for TLPPF (88) in the null industry. This means that RCUS’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's Profit vs Risk Rating (18) in the null industry is significantly better than the same rating for RCUS (100) in the Pharmaceuticals Major industry. This means that TLPPF’s stock grew significantly faster than RCUS’s over the last 12 months.

TLPPF's SMR Rating (74) in the null industry is in the same range as RCUS (97) in the Pharmaceuticals Major industry. This means that TLPPF’s stock grew similarly to RCUS’s over the last 12 months.

TLPPF's Price Growth Rating (58) in the null industry is in the same range as RCUS (61) in the Pharmaceuticals Major industry. This means that TLPPF’s stock grew similarly to RCUS’s over the last 12 months.

RCUS's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as TLPPF (100) in the null industry. This means that RCUS’s stock grew similarly to TLPPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTLPPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 10 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSTRX34.080.07
+0.21%
Federated Hermes MDT Large Cap Value A
NQCAX5.370.01
+0.19%
Nuveen Large Cap Value Opportunities A
OAZLX82.47-0.09
-0.11%
Oakmark Select R6
IIVLX20.46-0.07
-0.34%
Transamerica Small/Mid Cap Value C
HOOFX30.20-0.16
-0.53%
Hartford Schroders US Small Cap Opps F

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-2.87%
XNCR - RCUS
51%
Loosely correlated
-1.10%
IDYA - RCUS
48%
Loosely correlated
-2.26%
ACLX - RCUS
48%
Loosely correlated
-4.74%
TRDA - RCUS
48%
Loosely correlated
-1.88%
OCUL - RCUS
47%
Loosely correlated
-0.44%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and BDTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
+0.81%
BDTX - TLPPF
22%
Poorly correlated
-2.49%
ITOS - TLPPF
21%
Poorly correlated
N/A
RCUS - TLPPF
21%
Poorly correlated
-2.87%
ORMP - TLPPF
21%
Poorly correlated
N/A
ABOS - TLPPF
20%
Poorly correlated
+1.35%
More